Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Paxmedica Inc
(NQ:
PXMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Paxmedica Inc
< Previous
1
2
3
4
Next >
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD), Bourne Partners to Collaborate in Evaluating Future Monetization of Potential PRV
November 02, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV)
November 02, 2023
From
PaxMedica, Inc.
Via
GlobeNewswire
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Acquires Research Assets to Accelerate PAX-101 NDA Submission
October 31, 2023
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’
September 13, 2023
Via
Investor Brand Network
PaxMedica Appoints David Hough M.D. as Chief Medical Officer
August 16, 2023
Announces Additional Management Changes; Independent Directors Now Majority of Board
Via
NewMediaWire
PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences to Accelerate NDA Submission for PAX-101
October 31, 2023
From
PaxMedica, Inc.
Via
GlobeNewswire
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on 1-for-17 Reverse Stock Split
October 30, 2023
Via
Investor Brand Network
PaxMedica Announces 1-for-17 Reverse Stock Split
October 30, 2023
From
PaxMedica, Inc.
Via
GlobeNewswire
PaxMedica to Join Fireside Chat with PCG Advisory Following Positive Top Line Results from PAX-HAT-301 Study
August 08, 2023
Via
ACCESSWIRE
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Reports on Publication of Low-Dose Suramin for ASD Research
October 27, 2023
Via
Investor Brand Network
PaxMedica Inc.’s (NASDAQ: PXMD) CEO and Corporate Communications Chief Discuss Regulatory Strategy for Lead Drug Candidate and Future Plans in Recent Bell2Bell Podcast Interview
October 27, 2023
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Clearing Path to Submit NDA for PAX-101
October 26, 2023
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica's Research on Low Dose Suramin for Autism Spectrum Disorder Accepted for Publication
October 26, 2023
From
PaxMedica, Inc.
Via
GlobeNewswire
PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data
October 26, 2023
Via
ACCESSWIRE
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Spotlighted in Latest Episode of Bell2Bell Podcast
October 19, 2023
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Featured in Bell2Bell Podcast
October 18, 2023
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Announces Gold Sponsorship for The BRAIN Foundation’s Synchrony Symposia 2023
October 16, 2023
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) CEO Presents ASD Pipeline and Corporate Presentation at H.C. Wainwright 25th Annual Global Investment Conference
October 12, 2023
Via
Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) to Serve as Gold Sponsor of Synchrony Symposia 2023
October 10, 2023
Via
Investor Brand Network
PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023
October 10, 2023
Via
ACCESSWIRE
PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video: Progress Report on ASD and Hope for the Future
September 29, 2023
Via
Investor Brand Network
BioMedNewsBreaks – Why PaxMedica Inc. (NASDAQ: PXMD) Is ‘One to Watch’
September 22, 2023
Via
Investor Brand Network
Exposures
COVID-19
PaxMedica to Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 30, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update
August 09, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PaxMedica Grants Exclusive Pharmacy Distribution Rights for PAX-101 to Vox Nova, LLC
July 06, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PaxMedica Comments on Common Stock Volatility
June 22, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PaxMedica CEO Interviewed by The BRAIN Foundation
June 20, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
PaxMedica Submits Clinical Trial Request in Autism Spectrum Disorder
June 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Economy
Exposures
Supply Chain
InvestorNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Celebrates Listing and Autism Awareness
May 18, 2023
Via
Investor Brand Network
Exposures
COVID-19
PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023
May 15, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.